Sep 18, 2007 by Brian Orelli, PhDAnother Partnership for Personalized MedicineCelera gets a contract to design a companion diagnostic test for Merck.
Sep 18, 2007 by Brian Orelli, PhDPDUFA Reauthorization: Almost ThereThe PDUFA reauthorization moves one step closer to approval.
Sep 18, 2007 by Brian Orelli, PhDNew York Tag-Teams MerckBoth the city and state of New York sue Merck over Vioxx payments
Sep 17, 2007 by Brian Orelli, PhDCan't See the Trees for the ForestMeta-analysis finds J&J's stents are safer than Boston Scientific's stents -- maybe.
Sep 17, 2007 by Brian Orelli, PhDPreventing Cancer, No Bones About ItEli Lilly gets EVISTA approved for treating breast cancer.
Sep 14, 2007 by Brian Orelli, PhDJ&J's Expensive RNA PurchaseJohnson & Johnson sets up a collaboration with Isis Pharmaceuticals.
Sep 14, 2007 by Brian Orelli, PhDGood News About Propecia and CancerMerck's hair-loss remedy doesn't cause cancer. Instead, it helps doctors find tumors.
Sep 13, 2007 by Brian Orelli, PhDAlfacell's Awkward WaitWaiting for subjects to die is a somber part of the oncology clinical trial process.
Sep 13, 2007 by Brian Orelli, PhDProgenics ProgressesProgenics and partner Wyeth announce plans to start three new clinical trials.
Sep 12, 2007 by Brian Orelli, PhDFitting Fission at Abraxis BioScienceThe company will split into a biotech firm and a generic drug business.
Sep 12, 2007 by Brian Orelli, PhDButterflies Move EastwardSepracor and GlaxoSmithKline ink a deal to market Lunesta worldwide.
Sep 11, 2007 by Brian Orelli, PhDTeva Spending Plenty of Time in CourtThree patent disputes in one week keep the lawyers busy.
Sep 11, 2007 by Brian Orelli, PhDA Waiting Game for AsprevaIt will be three years before it and partner Roche evaluate results for a treatment for lupus.
Sep 10, 2007 by Brian Orelli, PhDDouble Your RNA PleasureAlnylam and ISIS join together to work on microRNAs.
Sep 7, 2007 by Brian Orelli, PhDClinical Data Gets PersonalLead compound Vilazodone posts strong phase 3 data.
Sep 7, 2007 by Brian Orelli, PhDMerck Says No to This ProteinAn advisory panel recommends approval of a new HIV drug that blocks one key element.
Sep 7, 2007 by Brian Orelli, PhDFighting the Generics Next DoorPfizer tries to stop patients from switching to generic Zocor.
Sep 6, 2007 by Brian Orelli, PhDFoolish Fantasy Football: 3 Drug CompaniesOffense, defense, special teams -- the industry has it all.
Aug 31, 2007 by Brian Orelli, PhDGuidelines to Stop the WheezingNew asthma guidelines will affect some drug makers.
